Subscribe to RSS
DOI: 10.1055/s-2007-990925
One-Pot Synthesis of 2H-Chromene Derivatives from ortho-Naphthoquinones
Publication History
Publication Date:
03 December 2007 (online)

Abstract
A general one-pot synthesis for 2H-chromenes is reported from ortho-naphthoquinones and allyltriphenylphosphonium salts, [(RMeC=CHCH2)Ph3P]+Br-, in the presence of aqueous NaOH and chloroform at room temperature.
Key words
chromenes - Wittig reaction - one-pot cyclisation - naphthoquinones
- 1
Katrikzy AR.Rees CW.Scriven EFV. In Comprehensive Heterocyclic Chemistry II Vol. 5:McKillop A. Elsevier Publishing Co.; Amsterdam: 1996. - 2
Bukuru JF.Van Tuyen N.Van Puyvelde L.Mathenge SG.Mudida FP.De Kimpe N. J. Nat. Prod. 2002, 65: 783 - 3
BenliSmane AF.Ponchus YF.Verbist JF.Petit J.-Y.Brion JD.Welin LJ. Clin. Pharmacol. 1995, 35: 298 -
4a
Engler TA.LaTessa KO.Iyengar R.Chai WY.Agrios K. Bioorg. Med. Chem. 1996, 4: 1755 -
4b
Yamagishi T.Fujioka T.Mihashi K.Mizuki K.Cosentino LM.Fowke K.Morris-Natschke SL.Lee KH. Tetrahedron 2001, 57: 1559 -
5a
Kidwai M.Saxena S.Khan MKR.Thukral SS. Bioorg. Med. Chem. Lett. 2005, 15: 4295 -
5b
Khafagy MM.Abd El-Wahab AHF.Eid FA.El-Agrody AM. Farmaco 2002, 57: 715 - For the preparation of cordiachromene, see:
-
6a
Bouzbouz S.Goujon JY.Deplanne J.Kirschleger B. Eur. J. Org. Chem. 2000, 3223 -
6b
Goujon JY.Zammattio F.Kirschleger B. Tetrahedron: Asymmetry 2000, 11: 2409 -
6c
Kahn PH.Cossy J. Tetrahedron Lett. 1999, 40: 8113 - 7
Ferreira VF.Pinto AV.Coutada LCM. Ann. Acad. Brasil. Cienc. 1980, 52: 478 - 8
Yavari I.Ramazani A. J. Chem. Res., Synop. 1996, 382 -
9a
Hekmatshoar R.Souri S.Faridbod F. Phosphorus, Sulfur Silicon Relat. Elem. 2003, 178: 1457 -
9b
Nicolaides DN.Lefkaditis DA.Lianis PS.Litinas KS. J. Chem. Soc., Perkin Trans. 1 1989, 2329 -
9c
Nicolaides DN.Adamopoulos SG.Hatzigrigorioub EJ.Litinas KE. J. Chem. Soc., Perkin Trans. 1 1991, 3159 -
9d
Nicolaides DN.Gautam DR.Litinas KE.Papamehael T. J. Chem. Soc., Perkin Trans. 1 2002, 1455 -
10a
Kumar P.Bodas MS. Org. Lett. 2000, 2: 3821 -
10b
Nicolaides DN.Litinas KE.Lefkaditas DA.Adamopoulos SG.Raptopoulou CP.Terzis A. J. Chem. Soc., Perkin Trans. 1 1994, 2107 -
10c
Nicolaides DN.Adamopoulos SG.Lefkaditas DA.Litinas KE. J. Chem. Soc., Perkin Trans. 1 1992, 2479 ; and earlier articles -
10d
Boulos LS.Elrahman NMA. Phosphorus, Sulfur Silicon Relat. Elem. 1992, 68: 241 - 11
Fieser LF. J. Am. Chem. Soc. 1926, 48: 2922 -
12a
Hooker SC. J. Chem. Soc. 1892, 611 -
12b
Pérez-Sacau E.Estévez-Braun A.Ravelo A.Ferro EA.Tokuda H.Mukainakac T.Nishino H. Bioorg. Med. Chem. 2003, 11: 483 -
12c
Pérez-Sacau E.Estévez-Braun A.Ravelo A.Yapu DG.Turba AG. Chem. Biodivers. 2005, 2: 264 - 13
Fieser LF.Fieser M. J. Am. Chem. Soc. 1948, 70: 3215 - 14
Alves GBC.Lopes RSC.Lopes CC.Snieckus V. Synthesis 1999, 1875 - 15
Reibenspies JH.Willams HJ.Ortiz C.Scout AI.Suarez M.Domínguez XA. J. Crystallogr. Spectrosc. Res. 1989, 19: 597 -
17a
Hooft RWW. COLLECT Nonius BV; Delft / The Netherlands: 1998. -
17b
Otwinowski Z.Minor W. Methods in Enzymology, Macromolecular Crystallography, Part A Vol. 276:Carter CW.Sweet RM. Academic Press; New York: 1997. p.307 -
17c
Sheldrick GM. SADABS, Version 2.10. Bruker AXS Inc.; Madison / Wisconsin / USA: 2003. -
17d
Farrugia LJ. J. Appl. Crystallogr. 1999, 32: 837 -
17e
Sheldrick GM. SHELXL-97: Program for Crystal Structure Refinement University of Göttingen; Germany: 1997. -
17f
Spek AL. J. Appl. Crystallogr. 2003, 36: 7 -
17g
Sheldrick GM. SHELXS-97: Program for the Solution of Crystal Structures University of Göttingen; Germany: 1997. -
19a
Li CJ.Wang C.Pardee BA. Cancer Res. 1995, 55: 3712 -
19b
Pardee AB.Li YZ.Li CJ. Curr. Cancer Drug Targets 2002, 2: 227 -
19c
Huang LL.Pardee AB. Mol. Med. 1999, 5: 711 -
19d
Li CJ.Averboukh L.Pardee AB. J. Biol. Chem. 1993, 268: 22463 -
19e
Frydman B.Marton LJ.Sun SJ.Neder K.Witiak TD.Liu AA.Wang HM.Mao Y.Wu HY.Sanders MM.Liu LF. Cancer Res. 1997, 57: 620 -
19f
Li CJ.Li Y.-Z.Pinto AV.Pardee AB. Proc. Natl. Acad. Sci. U.S.A. 1999, 96: 13369 -
20a
da Silva MN.Ferreira VF.de Souza MCBV. Quim. Nova 2003, 26: 407 -
20b
Dubin M.Fernadez-Villamil SH.Stoppani AO. Medicina 2001, 61: 343 -
21a
Ferreira VF.Jorqueira A.Souza AMT.da Silva MN.de Souza MCBV.Gouvêa RM.Rodrigues CR.Pinto AV.Castro HC.Santos DO.Araújo HP.Bourguignon SC. Bioorg. Med. Chem. 2006, 14: 5459 -
21b
Barbosa TP.Camara CA.Silva TMS.Martins RM.Pinto AV.Vargas MD. Bioorg. Med. Chem. 2005, 13: 6464 -
21c
Silva TMS.Camara CA.Barbosa TP.Soares AZ.da Cunha LC.Pinto AV.Vargas MD. Bioorg. Med. Chem. 2005, 13: 193 -
21d
de Moura KCG.Salomão K.Menna-Barreto RFS.Emery FS.Pinto MCFR.Pinto AV.Castro SL. Eur. J. Med. Chem. 2004, 39: 639
References and Notes
Data was obtained at 120 K with Mo KGk-α radiation by means of the Enraf Nonius KappaCCD area detector diffractometer of the EPSRC crystallographic service, based at the University of Southampton. Data collection was carried out under the control of the program COLLECT17a and data reduction and unit cell refinement were achieved with the COLLECT17a and DENZO programs.17b Correction for absorption, by comparison of the intensities of equivalent reflections, was applied using the program SADABS.17c The program ORTEP-3 for Windows17d was used in the preparation of Figure [3] and SHELXL-9717e and PLATON17f in the calculation of molecular geometry. The structure was solved by direct methods using SHELXS-9717g and fully refined by means of the program SHELXL-97.17e In the final stages of refinement, hydrogen atoms were introduced in calculated positions and refined with a riding model.
18Crystal data collected at 120 K, colourless crystal: 0.16 × 0.10 × 0.06 mm3. Formula: C20H22O2; M = 294.38; monoclinic, P21/c, a = 8.657(2) Å, b = 7.9525(17) Å, c = 23.385(6) Å, β = 92.815(9)°, Z = 4, V = 1608.0(7) Å3, 3696 independent reflections [R(int) = 0.1482], 1562 observed reflections [I >2s(I)]; parameters refined: 203; number of restraints: 0; R(F): 0.1839 (obs. data), Δρmax = 0.28 Å-3. CCDC deposition no: 292382.
22
General Procedure for 2
H
-Chromenes 7-10: A mixture of the naphthoquinone (0.02 mol), allyltriphenylphosphonium salt (0.04 mol), CHCl3 (15 mL) and aq 50% NaOH (15 mL, 0.19 mol) was vigorously stirred for 48 h at r.t. The organic phase was collected, washed with H2O (3 × 10 mL), dried over MgSO4 and the solvent was evaporated. Purification of the crude product was achieved by flash column chromatography using hexane-CH2Cl2 as eluent.
6-Methoxy-3,3-dimethyl-3
H
-benzo[
f
]chromene (7a): IR (KBr): 2971, 2938, 1634, 1588, 1574, 1515, 1464, 1450, 1443, 1411, 1379, 1351, 1283, 1247, 1220, 1207, 1199, 1160, 1130, 1119, 1092, 996, 981, 885, 841, 755, 727, 694, 626 cm-1. 1H NMR (300 MHz, CDCl3): δ = 1.50 (s, 6 H, Me), 3.98 (s, 3 H, OMe), 5.58 (d, J = 9.8 Hz, 1 H, H-2), 6.48 (s, 1 H, H-5), 6.95 (d, J = 9.8 Hz, 1 H, H-1), 7.30 (ddd, J = 1.2, 6.8, 8.5 Hz, 1 H, H-8), 7.49 (ddd, J = 1.2, 6.8, 8.3 Hz, 1 H, H-9), 7.89 (ddd, J = 0.7, 1.2, 8.3 Hz, 1 H, H-7), 8.17 (ddd, J = 0.7, 1.2, 8.5 Hz, 1 H, H-10). 13C NMR (75.0 MHz, CDCl3): δ = 27.4 (Me), 27.4 (Me), 55.5 (OMe), 76.2 (C-3), 97.4 (C-5), 106.8 (C-10b), 118.1 (C-1), 120.9 (C-10), 121.3 (C-6a), 122.3 (C-7), 122.5 (C-8), 126.0 (C-2), 127.1 (C-9), 130.4 (C-10a), 151.6 (C-4a), 156.4 (C-6). EIMS: m/z (%) = 240 (22) [M+], 225 (100), 210 (15). HRMS: m/z calcd for C16H16O2: 240.1150; found: 240.1139.
2,2,6,6-Tetramethyl-3,4-dihydro-2
H
,6
H
-1,5-dioxatri-phenylene (8a): mp 89-90 °C. IR (KBr): 2975, 2934, 1637, 1578, 1510, 1465, 1453, 1428, 1418, 1396, 1383, 1369, 1360, 1325, 1289, 1253, 1237, 1220, 1195, 1159, 1137, 1119, 1003, 974, 881, 762, 732, 710, 691, 665, 646 cm-1. 1H NMR (300 MHz, CDCl3): δ = 1.41 (s, 6 H, Me), 1.47 (s, 6 H, Me), 1.86 (t, J = 6.8 Hz, 2 H, H-3), 2.77 (t, J = 6.8 Hz, 2 H, H-4), 5.54 (d, J = 10.0 Hz, 1 H, H-7), 6.95 (d, J = 10.0 Hz, 1 H, H-8), 7.27 (ddd, J = 1.2, 6.8, 8.3 Hz, 1 H, H-11), 7.41 (ddd, J = 1.2, 6.8, 8.3 Hz, 1 H, H-10), 7.85 (ddd, J = 0.5, 1.2, 8.3 Hz, 1 H, H-12), 8.14 (ddd, J = 0.5, 1.2, 8.3 Hz, 1 H, H-9). 13C NMR (75 MHz, CDCl3): δ = 19.9 (C-4), 29.3 (Me), 29.3 (Me), 78.6 (C-6), 34.7 (C-3), 77.1 (C-2), 78.6 (C-6), 106.6 (C-8a), 110.3 (C-4a), 121.2 (C-9), 123.3 (C-12), 123.6 (C-12a), 124.6 (C-11), 124.8 (C-8), 128.0 (C-7), 128.7 (C-10), 131.6 (C-8b), 152.5 (C-4b), 152.6 (C-13). EIMS: m/z (%) = 294 (44) [M+], 279 (77), 223 (100). HRMS: m/z calcd for C20H22O2: 294.1620; found: 294.1617.
5,6,7,8-Tetrachloro-2,2-dimethyl-2
H
-chromene (10): yellow solid; mp 83-84 °C. IR (KBr): 2924, 2870, 2854, 1681, 1600, 1455, 1428, 1392, 1379, 1327, 1308, 1237, 1225, 1205, 1151, 1051, 1018, 996, 970, 924, 900, 834, 791, 663 cm-1. 1H NMR (300 MHz, CDCl3): δ = 1.87 (d, J = 1.5 Hz, 3 H, Me), 1.88 (d, J = 1.5 Hz, 3 H, Me), 5.55 (dsept, J = 1.5, 8.3 Hz, 1 H, H-2), 6.92 (d, J = 8.3 Hz, 1 H, H-1). 13C NMR (75 MHz, CDCl3): δ = 19.0 (Me), 26.4 (Me), 30.0 (C-3), 111.0 (C-1), 112.9 (C-5), 118.3 (C-2), 125.1 (C-8a), 126.0 (C-7), 128.0 (C-6), 144.9 (C-8), 146.7 (C-4a).